Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ·Healthcare·Biotechnology
$3.23
+1.73%
Mkt Cap $1.36B
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (7 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+241.1%
Consensus $11.00 vs current $3.23
NASDAQ·Healthcare·Biotechnology
$3.23
+1.73%
Mkt Cap $1.36B
Buy
3
Hold
2
Sell
0
Price Target (7 analysts)
$11.00
Range $11.00 – $11.00
+241.1%
Consensus $11.00 vs current $3.23